50242-0260 Phesgo - CanMED: NDC

Product NDC:

50242-0260

Brand Name:

Phesgo

Generic Name:

Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf

Dosage Form Name:

INJECTION, SOLUTION

Administration Route:

Subcutaneous

Substances:

Name: HYALURONIDASE (HUMAN RECOMBINANT)

Strength: 20000.0

Unit: U/10mL

Name: PERTUZUMAB

Strength: 600.0

Unit: mg/10mL

Name: TRASTUZUMAB

Strength: 600.0

Unit: mg/10mL

Packages:

Code: 50242-0260-01

Description: 1 VIAL, SINGLE-DOSE in 1 CARTON (50242-260-01) / 10 mL in 1 VIAL, SINGLE-DOSE

Effective Date: June 29, 2020

Discontinued:

Code: 50242-0260-86

Description: 1 VIAL, SINGLE-DOSE in 1 CARTON (50242-260-86) / 10 mL in 1 VIAL, SINGLE-DOSE

Effective Date: May 3, 2021

Discontinued:

SEER*Rx Category:

Immunotherapy

Major Class:

Monoclonal Antibody

Minor Class:

HER2

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox